HK1257593A1 - 治療糖尿病的新藥物及其用途 - Google Patents

治療糖尿病的新藥物及其用途

Info

Publication number
HK1257593A1
HK1257593A1 HK18116712.3A HK18116712A HK1257593A1 HK 1257593 A1 HK1257593 A1 HK 1257593A1 HK 18116712 A HK18116712 A HK 18116712A HK 1257593 A1 HK1257593 A1 HK 1257593A1
Authority
HK
Hong Kong
Prior art keywords
new drug
treating diabetes
diabetes
drug
treating
Prior art date
Application number
HK18116712.3A
Other languages
English (en)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257593A1 publication Critical patent/HK1257593A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
HK18116712.3A 2016-12-15 2018-12-28 治療糖尿病的新藥物及其用途 HK1257593A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611162269 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257593A1 true HK1257593A1 (zh) 2019-10-25

Family

ID=62657342

Family Applications (6)

Application Number Title Priority Date Filing Date
HK18116715.0A HK1257596A1 (zh) 2016-12-15 2018-12-28 一種促進胰島素分泌的方法
HK18116718.7A HK1257599A1 (zh) 2016-12-15 2018-12-28 一種促進胰島素受體底物-2表達的方法
HK18116714.1A HK1257595A1 (zh) 2016-12-15 2018-12-28 抑制胰島β細胞凋亡的藥物及其用途
HK18116716.9A HK1257597A1 (zh) 2016-12-15 2018-12-28 一種使胰高血糖素、胰島素恢復正常平衡的方法
HK18116713.2A HK1257594A1 (zh) 2016-12-15 2018-12-28 一種促進胰島β細胞損傷修復和減少胰島纖維化的方法
HK18116712.3A HK1257593A1 (zh) 2016-12-15 2018-12-28 治療糖尿病的新藥物及其用途

Family Applications Before (5)

Application Number Title Priority Date Filing Date
HK18116715.0A HK1257596A1 (zh) 2016-12-15 2018-12-28 一種促進胰島素分泌的方法
HK18116718.7A HK1257599A1 (zh) 2016-12-15 2018-12-28 一種促進胰島素受體底物-2表達的方法
HK18116714.1A HK1257595A1 (zh) 2016-12-15 2018-12-28 抑制胰島β細胞凋亡的藥物及其用途
HK18116716.9A HK1257597A1 (zh) 2016-12-15 2018-12-28 一種使胰高血糖素、胰島素恢復正常平衡的方法
HK18116713.2A HK1257594A1 (zh) 2016-12-15 2018-12-28 一種促進胰島β細胞損傷修復和減少胰島纖維化的方法

Country Status (2)

Country Link
CN (7) CN108210901A (zh)
HK (6) HK1257596A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111411072B (zh) * 2020-03-09 2022-10-11 同济大学 SLC30A8基因表达下调的抗糖尿病胰岛β细胞及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7067492B2 (en) * 2001-09-06 2006-06-27 Omnio Ab Method of promoting healing of a tympanic membrane perforation
MXPA04007585A (es) * 2002-02-06 2005-09-20 N Zyme Biotec Gmbh Metodo para la produccion de proteinas recombinantes en microorganismos.
CA2888996A1 (en) * 2012-10-31 2014-05-08 The Regents Of The University Of Michigan Plasminogen activator inhibitor-1 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
HK1257596A1 (zh) 2019-10-25
CN108210912A (zh) 2018-06-29
HK1257599A1 (zh) 2019-10-25
HK1257597A1 (zh) 2019-10-25
CN108210907A (zh) 2018-06-29
CN108210911A (zh) 2018-06-29
HK1257594A1 (zh) 2019-10-25
CN108210901A (zh) 2018-06-29
CN108210913A (zh) 2018-06-29
HK1257595A1 (zh) 2019-10-25
CN108339114A (zh) 2018-07-31
CN108210903A (zh) 2018-06-29

Similar Documents

Publication Publication Date Title
HK1249103B (zh) 多環氨甲醯基吡啶酮化合物及其藥物用途
HK1244000B (zh) 多環氨基甲酰吡啶酮化合物及其藥物用途
IL246757A0 (en) New insulin histories and their medical uses
IL283335B (en) Dihydropyrimidine-2-one compounds and their medical use
IL257173A (en) New insulin histories and their medical uses
GB201617064D0 (en) Compounds and their therapeutic use
SG11201705194XA (en) Pharmaceutical composition for treating diabetes
SG11201609948YA (en) Lobaplatin crystal, preparation method and pharmaceutical application
PT3406258T (pt) Medicamento para utilização no tratamento de gota
GB201406172D0 (en) Therapy and pharmaceutical composition
ZA201802845B (en) Oxadiazaspiro compounds for the treatment of drug abuse and addiction
HK1257593A1 (zh) 治療糖尿病的新藥物及其用途
GB201519644D0 (en) Therapy and pharmaceutical composition
PT3129398T (pt) Novos agentes médicos e usos dos mesmos
GB201418541D0 (en) Materials for use with general hyperthermia treatment
GB201702652D0 (en) Delta-theraphotoxin-Ac1 for use in treating diabetes
SG10201400823PA (en) Therapeutic methods and compositions for treating diabetes